Cross-campus initiative to accelerate innovations in engineering, medicine

Weill Cornell Medicine and Cornell Engineering are launching an initiative, led by Emmanuel Giannelis, to form cross-disciplinary partnerships.

Study sheds light on precancerous ‘clonal outgrowth’ in blood cells

The blood stem cell mutation, known as DNMT3A R882leads to the growth of a large population of circulating blood cells that also contain this mutation.

Discovery illuminates how Parkinson’s disease spreads in the brain

Aggregates of a protein spread in the brains of people with Parkinson’s disease through a cellular waste-ejection process, suggests a new study led by Weill Cornell Medicine researchers.

Aggressive breast cancer linked to African ancestry

Weill Cornell Medicine investigators have identified definitive biological links between African ancestry and disease processes that affect an aggressive cancer type called triple-negative breast cancer.

Alzheimer’s disease causes major metabolic changes in the brain

New findings could lead to the development of treatments aimed at ameliorating the metabolic effects of the disease.

Protecting privacy – and safety – in encrypted messaging

Cornell Tech researchers have developed a mechanism for preserving anonymity in encrypted messaging – which conceals message content but might not cloak the sender’s identity – while simultaneously blocking unwanted or abusive messages.

$61M grant funds translational science at Weill Cornell Medicine

This is the largest federal grant ever awarded to Weill Cornell Medicine and the fourth consecutive time this initiative has been funded by the NIH, representing 20 years of continuous funding.

Cells help immune system tolerate friendly gut bacteria

Immune cells called group 3 innate lymphoid cells play an essential role in establishing tolerance to symbiotic microbes that dwell in the human gastrointestinal tract, according to a study led by researchers at Weill Cornell Medicine.

Researchers identify the target of immune attacks on liver cells

A new study from Weill Cornell Medicine researchers helps to explain the dynamics underlying liver damage that can accompany type 2 diabetes and obesity.